相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Multi-action and Multi-target RuII-PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
Johannes Karges et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
Maria V. Babak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Organic Photodynamic Nanoinhibitor for Synergistic Cancer Therapy
Yuyan Jiang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Targeted photoredox catalysis in cancer cells
Huaiyi Huang et al.
NATURE CHEMISTRY (2019)
New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy
Jiayang Li et al.
SCIENCE ADVANCES (2019)
Stimuli-Responsive Therapeutic Metallodrugs
Xiaohui Wang et al.
CHEMICAL REVIEWS (2019)
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny et al.
CHEMICAL REVIEWS (2019)
Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
Tiantian Fang et al.
NATURE COMMUNICATIONS (2019)
Modular design of nanobody-drug conjugates for targeted-delivery of platinum anticancer drugs with an MRI contrast agent
Hai Huang et al.
CHEMICAL COMMUNICATIONS (2019)
Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt-IV Anticancer Prodrug
Lili Ma et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
Elisabetta Gabano et al.
DALTON TRANSACTIONS (2018)
Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach
Hyo Sung Jung et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Comparative studies of oxaliplatin-based platinum(IV) complexes in different in vitro and in vivo tumor models
Simone Goeschl et al.
METALLOMICS (2017)
A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines
Emanuele Petruzzella et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Novel hypoxia-targeting Pt(IV) prodrugs
Zichen Xu et al.
CHEMICAL COMMUNICATIONS (2017)
A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
Zhigang Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Behavior of platinum(IV) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation
Ekaterina Schreiber-Brynzak et al.
METALLOMICS (2016)
Carbonic anhydrase IX inhibitors in cancer therapy: an update
Claudiu T. Supuran et al.
FUTURE MEDICINAL CHEMISTRY (2015)
A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
Samuel G. Awuah et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Induction of targeted necrosis with HER2-targeted platinum(IV) anticancer prodrugs
Daniel Yuan Qiang Wong et al.
CHEMICAL SCIENCE (2015)
Encapsulation of Pt(IV) prodrugs within a Pt(II) cage for drug delivery
Yao-Rong Zheng et al.
CHEMICAL SCIENCE (2015)
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models
Carol Ward et al.
ONCOTARGET (2015)
Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
Daniel Yuan Qiang Wong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
Disrupting proton dynamics and energy metabolism for cancer therapy
Scott K. Parks et al.
NATURE REVIEWS CANCER (2013)
[(Cp-R)M(CO)3] (M=Re or 99mTc) Arylsulfonamide, Arylsulfamide, and Arylsulfamate Conjugates for Selective Targeting of Human Carbonic Anhydrase IX
Daniel Can et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
Giuseppina De Simone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer
R. A. Gatenby et al.
BRITISH JOURNAL OF CANCER (2007)
Regulation of tumor pH and the role of carbonic anhydrase 9
Pawel Swietach et al.
CANCER AND METASTASIS REVIEWS (2007)
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro
JL Carr et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance
WH Ang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response
P Vaupel et al.
ONCOLOGIST (2004)
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
